Sym021 Monotherapy, in Combination With Sym022 or Sym023, and in Combination With Both Sym022 and Sym023 in Patients With Advanced Solid Tumor Malignancies or Lymphomas
Clinical trial NCT03311412 · COMPLETED
Trial details
- NCT number
- NCT03311412
- Sponsor
- Symphogen A/S
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2017-11-20
- Primary completion
- 2022-03-23
- Enrollment
- 89
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.